- Home
- Jobs
- Biometrics
- Director, Biostatistics, Pulmovant

Director, Biostatistics, Pulmovant at Pulmovant
Remote, USFull-timeRemoteBiometricsPosted 20 days ago
Apply with PipelineAbout the Role
<p><span data-contrast="auto">Pulmovant is a Roivant-backed clinical-stage biotechnology company committed to transforming the lives of patients with pulmonary diseases. Pulmovant’s first investigational candidate, mosliciguat, is designed to provide a novel, once-daily, inhaled treatment option for patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD). Mosliciguat is a potential first-in-class soluble guanylate cyclase activator with a differentiated mechanism of action currently being evaluated in the Phase 3 PHrontier global clinical trial in PH-ILD, but with potential broad applicability across the PH and ILD disease landscape. </span><span data-ccp-props="{}"> </span></p>
<p><span data-contrast="auto">Pulmovant recently announced positive results from its Phase 2 PHocus study evaluating mosliciguat for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD), a progressive and life-threatening condition with significant unmet medical needs for patients. PHocus met both primary and secondary endpoints including the highest ever reported pulmonary vascular resistance (PVR) reduction in any randomized controlled PH trial. The robust results, in conjunction with mosliciguat’s once-daily, inhaled administration and potential first-in-class sGC activator profile, strongly position it as a potential single agent treatment and combination therapy for patients with PH-ILD. These data represent a significant advancement in a devastating disease that affects ~200,000 patients with no or very limited treatment options. A Phase 3 trial is currently underway. More details can be found in the press release </span><a href="https://investor.roivant.com/news-releases/news-release-details/roivant-announces-positive-results-phocus-study-mosliciguat"><span data-contrast="none"><span data-ccp-charstyle="Hyperlink">here</span></span></a><span data-contrast="auto">.</span><span data-ccp-props="{}"> </span></p>
<p><span data-contrast="auto">As part of the Roivant family of companies, Pulmovant leverages the power of collaboration and innovation to drive progress.</span><span data-ccp-props="{}"> </span></p>
<p><span data-contrast="auto">For more information, please visit </span><a href="https://www.pulmovant.com/"><span data-contrast="none"><span data-ccp-charstyle="Hyperlink">https://www.pulmovant.com</span></span></a><span data-contrast="auto">.</span><span data-ccp-props="{}"> </span></p>
<p><strong><span data-contrast="auto">About Roivant:</span></strong><span data-ccp-props="{}"> </span></p>
<p><span data-contrast="auto">Roivant (Nasdaq: ROIV) is a commercial-stage biopharmaceutical company that aims to improve the lives of patients by accelerating the development and commercialization of medicines that matter. Roivant’s pipeline includes LISRAYA™ (brepocitinib), a potent small molecule inhibitor of JAK1 and TYK2 FDA-approved for the treatment of dermatomyositis in adult patients and also in late-stage development for the treatment of non-infectious uveitis, cutaneous sarcoidosis and lichen planopilaris; IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; and mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease. We advance our pipeline by creating nimble subsidiaries or “Vants” to develop and commercialize our medicines and technologies. For more information, visit </span><a href="http://www.roivant.com/"><span data-contrast="none"><span data-ccp-charstyle="Hyperlink">www.roivant.com</span></span></a><span data-contrast="auto">. </span><span data-ccp-props="{}"> </span></p>
<p><strong><span data-contrast="auto">Position: </span></strong><span data-contrast="auto">Director, Biostatistics</span><span data-ccp-props="{"335551550":6,"335551620":6,"335559739":120}"> </span></p>
<p><strong><span data-contrast="auto"><span data-ccp-parastyle="No Spacing">Summary:</span></span></strong><span data-contrast="auto"><span data-ccp-parastyle="No Spacing"> </span></span><span data-ccp-props="{}"> </span></p>
<p><span data-contrast="auto">Pulmovant is seeking a Director of Biostatistics to serve as lead biostatistician for its Phase 3 PHrontier program evaluating mosliciguat in pulmonary hypertension associated with interstitial lung disease (PH-ILD). This role will drive statistical strategy for the pivotal trial, partnering closely with Clinical Development, Regulatory, and Data Management to ensure rigorous, submission-ready trial design and analysis. The ideal candidate brings direct experience taking a program through Phase 3 and toward regulatory filing.</span><span data-ccp-props="{"335551550":6,"335551620":6,"335559739":120}"> </span></p>
<p><strong><span data-contrast="auto"><span data-ccp-parastyle="No Spacing">Key</span></span></strong><strong><span data-contrast="auto"><span data-ccp-parastyle="No Spacing"> </span></span></strong><strong><span data-contrast="auto"><span data-ccp-parastyle="No Spacing">Duties and Responsibilities </span></span></strong><span data-ccp-props="{}"> </span></p>
<ul>
<li data-leveltext="·" data-font="Symbol" data-listid="46" data-list-defn-props="{"335552541":1,"335559685":720,"335559991":360,"469769226":"Symbol","469769242":[8226],"469777803":"left","469777804":"·","469777815":"hybridMultilevel"}" data-aria-posinset="1" data-aria-level="1"><span data-contrast="auto"><span data-ccp-parastyle="No Spacing">Serve as lead biostatistician for </span><span data-ccp-parastyle="No Spacing">Pulmovant's</span><span data-ccp-parastyle="No Spacing"> Phase 3 </span><span data-ccp-parastyle="No Spacing">PHrontier</span><span data-ccp-parastyle="No Spacing"> program, including protocol development, statistical analysis plans (SAPs), and sample size/power calculations</span></span><span data-ccp-props="{}"> </span></li>
<li><span data-contrast="auto"><span data-ccp-parastyle="No Spacing">Partner with Clinical Development and Regulatory on trial design decisions, including endpoint selection and interim analysis strategy</span></span><span data-ccp-props="{}"> </span></li>
<li data-leveltext="·" data-font="Symbol" data-listid="46" data-list-defn-props="{"335552541":1,"335559685":720,"335559991":360,"469769226":"Symbol","469769242":[8226],"469777803":"left","469777804":"·","469777815":"hybridMultilevel"}" data-aria-posinset="3" data-aria-level="1"><span data-contrast="auto"><span data-ccp-parastyle="No Spacing">Oversee CRO/vendor biostatistics deliverables, ensuring quality and timeline adherence</span></span><span data-ccp-props="{}"> </span></li>
<li><span data-contrast="auto"><span data-ccp-parastyle="No Spacing">Lead statistical input for regulatory submissions (e.g., NDA/BLA), including responses to health authority queries</span></span><span data-ccp-props="{}"> </span></li>
<li data-leveltext="·" data-font="Symbol" data-listid="46" data-list-defn-props="{"335552541":1,"335559685":720,"335559991":360,"469769226":"Symbol","469769242":[8226],"469777803":"left","469777804":"·","469777815":"hybridMultilevel"}" data-aria-posinset="5" data-aria-level="1"><span data-contrast="auto"><span data-ccp-parastyle="No Spacing">Collaborate with Data Management on CRF design, database structure, and data quality standards</span></span><span data-ccp-props="{}"> </span></li>
<li><span data-contrast="auto"><span data-ccp-parastyle="No Spacing">Present statistical results and </span><span data-ccp-parastyle="No Spacing">methodology</span><span data-ccp-parastyle="No Spacing"> to internal leadership and external stakeholders (e.g., DSMBs, advisory boards)</span></span><span data-ccp-props="{}"> </span></li>
<li><span data-contrast="auto"><span data-ccp-parastyle="No Spacing">Mentor junior biostatistics staff or contractors as the function scales</span></span><span data-ccp-props="{}"> </span></li>
<li data-leveltext="·" data-font="Symbol" data-listid="46" data-list-defn-props="{"335552541":1,"335559685":720,"335559991":360,"469769226":"Symbol","469769242":[8226],"469777803":"left","469777804":"·","469777815":"hybridMultilevel"}" data-aria-posinset="8" data-aria-level="1"><span data-contrast="auto"><span data-ccp-parastyle="No Spacing">Contribute to departmental</span><span data-ccp-parastyle="No Spacing"> initiatives,</span><span data-ccp-parastyle="No Spacing"> standards, process improvements, talent development, resource planning, and </span><span data-ccp-parastyle="No Spacing">inspection</span><span data-ccp-parastyle="No Spacing"> readiness.</span></span><span data-ccp-props="{}"> </span></li>
</ul>
<p><strong><span data-contrast="auto"><span data-ccp-parastyle="No Spacing">Education and Experience </span></span></strong><span data-ccp-props="{}"> </span></p>
<ul>
<li data-leveltext="·" data-font="Symbol" data-listid="47" data-list-defn-props="{"335552541":1,"335559685":720,"335559991":360,"469769226":"Symbol","469769242":[8226],"469777803":"left","469777804":"·","469777815":"hybridMultilevel"}" data-aria-posinset="1" data-aria-level="1"><span data-contrast="auto"><span data-ccp-parastyle="No Spacing">PhD or MS in Biostatistics, Statistics, or related field</span></span><span data-ccp-props="{}"> </span></li>
<li><span data-contrast="auto"><span data-ccp-parastyle="No Spacing">8+ years of biostatistics experience in clinical drug development, including direct Phase 3 experience</span></span><span data-ccp-props="{}"> </span></li>
<li data-leveltext="·" data-font="Symbol" data-listid="47" data-list-defn-props="{"335552541":1,"335559685":720,"335559991":360,"469769226":"Symbol","469769242":[8226],"469777803":"left","469777804":"·","469777815":"hybridMultilevel"}" data-aria-posinset="3" data-aria-level="1"><span data-contrast="auto"><span data-ccp-parastyle="No Spacing">Prior experience contributing to a regulatory submission (NDA/BLA) strongly preferred</span></span><span data-ccp-props="{}"> </span></li>
<li><span data-contrast="auto"><span data-ccp-parastyle="No Spacing">Pulmonary/respiratory therapeutic area experience a plus</span></span><span data-ccp-props="{}"> </span></li>
</ul>
<p><strong><span data-contrast="auto"><span data-ccp-parastyle="No Spacing">Essential Skills and Abilities </span></span></strong><span data-ccp-props="{}"> </span></p>
<ul>
<li data-leveltext="·" data-font="Symbol" data-listid="48" data-list-defn-props="{"335552541":1,"335559685":720,"335559991":360,"469769226":"Symbol","469769242":[8226],"469777803":"left","469777804":"·","469777815":"hybridMultilevel"}" data-aria-posinset="1" data-aria-level="1"><span data-contrast="auto"><span data-ccp-parastyle="No Spacing">Deep </span><span data-ccp-parastyle="No Spacing">expertise</span><span data-ccp-parastyle="No Spacing"> in SAS and/or R for clinical trial analysis</span></span><span data-ccp-props="{}"> </span></li>
<li><span data-contrast="auto"><span data-ccp-parastyle="No Spacing">Strong understanding of ICH/FDA statistical guidance and GCP</span><span data-ccp-parastyle="No Spacing">, ICH standards, and CDISC principles</span></span><span data-ccp-props="{}"> </span></li>
<li data-leveltext="·" data-font="Symbol" data-listid="48" data-list-defn-props="{"335552541":1,"335559685":720,"335559991":360,"469769226":"Symbol","469769242":[8226],"469777803":"left","469777804":"·","469777815":"hybridMultilevel"}" data-aria-posinset="3" data-aria-level="1"><span data-contrast="auto"><span data-ccp-parastyle="No Spacing">Experience managing CRO biostatistics relationships</span></span><span data-ccp-props="{}"> </span></li>
<li><span data-contrast="auto"><span data-ccp-parastyle="No Spacing">Excellent cross-functional communication skills, able to translate statistical findings for non-statistician stakeholders</span></span><span data-ccp-props="{}"> </span></li>
<li data-leveltext="·" data-font="Symbol" data-listid="48" data-list-defn-props="{"335552541":1,"335559685":720,"335559991":360,"469769226":"Symbol","469769242":[8226],"469777803":"left","469777804":"·","469777815":"hybridMultilevel"}" data-aria-posinset="5" data-aria-level="1"><span data-contrast="auto"><span data-ccp-parastyle="No Spacing">Comfortable operating in a lean, scaling clinical-stage environment</span></span><span data-ccp-props="{}"> </span></li>
</ul>
<p> </p>
<p><span data-contrast="auto"><span data-ccp-parastyle="No Spacing">Pulmovant</span><span data-ccp-parastyle="No Spacing"> provides equal employment opportunities to all employees and applicants for employment and prohibits discrimination and harassment of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by federal, state or local laws. </span></span><span data-ccp-props="{}"> </span></p>
<p><span data-contrast="auto"><span data-ccp-parastyle="No Spacing">We will not accept unsolicited resumes </span><span data-ccp-parastyle="No Spacing">nor</span><span data-ccp-parastyle="No Spacing"> outreach from agencies. Please do not send agency resumes to our website or Roivant Sciences and affiliated employees. Thanks!</span></span><span data-ccp-props="{}"> </span></p>
Related Roles
Manager/Senior Manager, Statistical Programming, Pulmovant
Pulmovant
Remote, USRemoteSenior Manager / Associate Director, CMC Project Management, Pulmovant
Pulmovant
RemoteRemoteExecutive Assistant, Pulmovant
Pulmovant
Remote, USRemoteSenior Manager, Program Management, PH-ILD, Pulmovant
Pulmovant
Remote, USRemoteSenior Manager, Clinical Supply, Pulmovant
Pulmovant
Remote, USRemoteSenior Director, Regulatory Affairs, Pulmovant
Pulmovant
Remote, USRemote